Status:

UNKNOWN

Stepwise Approach Versus Linear Ablation in Patients With Recurrence of Persistent Atrial Fibrillation

Lead Sponsor:

Deutsches Herzzentrum Muenchen

Conditions:

Atrial Fibrillation

Recurrence

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Catheter ablation of persistent atrial fibrillation (AF) remains a challenging procedure. Even in experienced centres, repeat interventions are necessary in up to 70 of patients to achieve sinus rhyth...

Eligibility Criteria

Inclusion

  • Patients with recurrence of symptomatic persistent atrial fibrillation after at least one ablation procedure,
  • with the last ablation procedure at least 3 months ago.
  • at least one unsuccessful attempt of antiarrhythmic drug
  • oral anticoagulation for at least 4 weeks prior to ablation

Exclusion

  • LA thrombus

Key Trial Info

Start Date :

October 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2013

Estimated Enrollment :

130 Patients enrolled

Trial Details

Trial ID

NCT01229475

Start Date

October 1 2010

End Date

December 1 2013

Last Update

March 1 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Deutsches Herzzentrum München

Munich, Germany, 80636